Prior research conducted in Germany [25], Italy [19], and South Africa [36] established that the IL-6 G174C SNP was associated with increased circulating levels of IL-6, as well as an increased risk of developing cardiovascular disease and mortality in CKD patients. Here, IL6 is linked to cardiovascular disorder.